Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,142,630 | 2,136,890 | 1,947,860 | 1,772,020 | 2,115,740 |
| Marketable Securities | 719,260 | 110,200 | 101,060 | 120,520 | 286,560 |
| Receivables | 1,515,550 | 1,473,090 | 1,480,860 | 1,514,780 | 1,322,890 |
| Inventories | 1,727,540 | 1,689,170 | 1,717,860 | 1,910,770 | 1,875,990 |
| Other current assets | 544,360 | 459,320 | 528,740 | 519,140 | 517,160 |
| TOTAL | $6,649,340 | $5,868,670 | $5,776,380 | $5,837,230 | $6,118,340 |
| Non-Current Assets | |||||
| Investments And Advances | 7,660 | 47,400 | 48,390 | 52,450 | 32,960 |
| Other Non-Current Assets | 634,560 | 512,240 | 500,170 | 553,890 | 500,830 |
| TOTAL | $642,220 | $559,640 | $548,560 | $606,340 | $533,790 |
| Total Assets | $10,947,970 | $9,889,020 | $9,755,200 | $10,072,830 | $10,253,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 306,670 | 173,170 | 558,820 | 192,690 | 0 |
| Accounts payable and accrued liabilities | 518,130 | 346,860 | 402,700 | 364,370 | 419,920 |
| Accrued Expenses | 223,230 | 219,880 | 104,820 | 122,940 | 131,290 |
| Other current liabilities | 2,246,220 | 2,188,790 | 2,060,890 | 2,206,700 | 1,883,110 |
| TOTAL | $3,294,270 | $2,928,710 | $3,127,240 | $2,886,720 | $2,512,620 |
| Non-Current Liabilities | |||||
| Long Term Debt | 89,860 | 172,130 | 174,070 | 180,040 | 181,680 |
| aiOther Non-Current Liabilities | 462,150 | 351,360 | 305,230 | 308,010 | 302,110 |
| TOTAL | $1,062,830 | $1,032,620 | $876,360 | $1,063,720 | $1,047,560 |
| Total Liabilities | $4,357,110 | $3,961,350 | $4,003,620 | $3,950,450 | $3,560,190 |
| Shareholders' Equity | |||||
| Common Shares | 106,980 | 103,800 | 102,600 | 115,320 | 116,120 |
| Retained earnings | 6,436,090 | 5,828,370 | 5,652,060 | 6,013,380 | 6,449,670 |
| Other shareholders' equity | 52,780 | -500 | -80 | -330 | 133,180 |
| TOTAL | $6,590,850 | $5,927,670 | $5,751,580 | $6,122,370 | $6,692,970 |
| Total Liabilities And Equity | $10,947,960 | $9,889,020 | $9,755,200 | $10,072,820 | $10,253,160 |